Mouiman Soukaina, Essebbagh Youssef, Lamrani Meryem, Slaoui Aziz, Baidada Aziz
Gynaecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.
Gynaecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.
Int J Surg Case Rep. 2025 May;130:111197. doi: 10.1016/j.ijscr.2025.111197. Epub 2025 Mar 24.
Endometrial polyps are common in both menopausal and non-menopausal patients, often detected incidentally or presenting with abnormal uterine bleeding or infertility. While the malignancy risk is generally low, malignant transformation is possible. This paper highlights a case of malignant transformation in an endometrial polyp and reviews its diagnostic methods, treatment, and prognosis.
A 68-year-old postmenopausal woman presented with metrorrhagia. Clinical and imaging assessments revealed an endometrial polyp, confirmed via hysteroscopy. She underwent polypectomy, and histopathology identified a Grade 1 endometrioid adenocarcinoma arising from the polyp, classified as a POLE-mutated carcinoma. The POLE mutation was identified using molecular sequencing rather than immunohistochemistry. Further evaluations, including pelvic MRI and thoraco-abdominopelvic CT, showed no myometrial invasion or metastasis. Definitive management involved a total hysterectomy with bilateral salpingo-oophorectomy. Histological examination of the surgical specimen confirmed the diagnosis, and the patient remained disease-free during follow-up.
Endometrial polyps are common localized intrauterine lesions influenced by estrogen and progesterone. Their prevalence varies widely, with higher rates in postmenopausal women and those with risk factors such as obesity, hypertension, and tamoxifen use. While most polyps are benign, the risk of malignancy ranges from 0.5 % to 5.4 %, increasing with age, menopausal status, and abnormal uterine bleeding. Recent studies in South Korea reported a 7.2 % prevalence of precancerous or malignant lesions, identifying menopause, abnormal bleeding, obesity, multiple polyps, and nulliparity as key risk factors. Meta-analyses confirm a malignancy rate of approximately 3 %, rising to 5 % in symptomatic or postmenopausal women. The presence of abnormal uterine bleeding in a postmenopausal patient should prompt histopathological examination of polyps, as demonstrated in this case.
Abnormal uterine bleeding and menopause notably raise the risk of malignancy in endometrial polyps. Histological evaluation of resected polyps is crucial, even when clinical suspicion is low, as demonstrated by our case of adenocarcinoma identified in a polyp. Proper adherence to established guidelines for the management of postmenopausal bleeding and endometrial thickening remains essential.
子宫内膜息肉在绝经和未绝经患者中都很常见,常为偶然发现或表现为子宫异常出血或不孕。虽然恶性风险一般较低,但恶变是有可能的。本文重点介绍一例子宫内膜息肉恶变病例,并对其诊断方法、治疗及预后进行综述。
一名68岁绝经后女性出现子宫出血。临床及影像学评估发现一个子宫内膜息肉,经宫腔镜检查确诊。她接受了息肉切除术,组织病理学检查发现息肉发生了1级子宫内膜样腺癌,归类为POLE突变型癌。POLE突变通过分子测序而非免疫组化确定。进一步评估,包括盆腔MRI和胸腹部盆腔CT,显示无肌层浸润或转移。最终治疗方案为全子宫切除术加双侧输卵管卵巢切除术。手术标本的组织学检查证实了诊断,患者在随访期间无疾病复发。
子宫内膜息肉是常见的子宫局部病变,受雌激素和孕激素影响。其患病率差异很大,绝经后女性以及有肥胖、高血压和使用他莫昔芬等危险因素的女性患病率较高。虽然大多数息肉是良性的,但恶性风险在0.5%至5.4%之间,随年龄、绝经状态和子宫异常出血而增加。韩国最近的研究报告癌前或恶性病变患病率为7.2%,确定绝经、异常出血、肥胖、多发息肉和未生育为关键危险因素。荟萃分析证实恶性率约为3%,有症状或绝经后女性中升至5%。如本病例所示,绝经后患者出现子宫异常出血应促使对息肉进行组织病理学检查。
子宫异常出血和绝经显著增加子宫内膜息肉恶变风险。即使临床怀疑程度低,对切除息肉进行组织学评估也至关重要,如我们在息肉中发现腺癌的病例所示。正确遵循绝经后出血和子宫内膜增厚的既定管理指南仍然至关重要。